01/04/2023
Friends, Do NOT miss this exciting, first in series webinar on Pandemic Preparedness through science, January 10 with Ken Duncan Bill & Melinda Gates Foundation, hosted by The National Academies of Sciences, Engineering, and Medicine National Academy of Sciences and the U.S. National Committee for the International Union of Pure and Applied Chemistry (USNC/IUPAC), the US National Committee for Crystallography (USNC/Cr), and the US National Committee for CODATA (USNC/CODATA). Registration in link for a valuable 60 minutes.
Thank you to our sponsors: Thermo Fisher Scientific & Schrödinger
The COVID-19 pandemic showed how poorly prepared we were to deal with a newly-emerging respiratory virus. Antiviral drugs with the appropriate spectrum of activity can protect against a new pandemic threat until a vaccine can be developed and deployed. Drugs should be suitable for post-exposure prophylaxis or treatment of mild disease, possess oral activity with a good safety profile, have low cost of goods, and be easy to deliver and suitable for combination. The global research community must act collectively to generate a toolkit of antiviral agents covering a number of viral families. Scientists from many sectors – industry, academia, non-profits – will be involved, working in a multidisciplinary effort. This presentation provides a perspective on pandemic preparedness, the approaches that are being taken to tackle this problem, and the need to ensure equitable access to any drugs that are developed.
Ken Duncan is Deputy Director of Discovery & Translational Sciences within the Global Health Program of the Bill & Melinda Gates Foundation. He leads the foundation’s efforts in drug discovery across therapeutic areas currently including TB, malaria, antivirals and contraception. He recently coordinated the drug discovery response to COVID-19 then developed and is implementing a strategy for pandemic preparedness to identify safe, effective agents that can be deployed in low-resource settings.
See you soon! Ana Ferreras Leah Frye KB Science
KB Science LLC
National Academies of Sciences, Engineering, and Medicine
Learn more from the National Academies of Sciences, Engineering, and Medicine
